SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-028715
Filing Date
2024-02-28
Accepted
2024-02-28 16:08:40
Documents
19
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247340d5_8k.htm   iXBRL 8-K 33553
2 EXHIBIT 1.1 tm247340d5_ex1-1.htm EX-1.1 230012
3 EXHIBIT 5.1 tm247340d5_ex5-1.htm EX-5.1 11089
7 GRAPHIC tm247340d5_ex5-1img003.jpg GRAPHIC 5061
8 GRAPHIC tm247340d5_ex5-1img004.jpg GRAPHIC 21183
9 GRAPHIC tm247340d5_ex5-1img005.jpg GRAPHIC 3346
  Complete submission text file 0001104659-24-028715.txt   547035

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrsn-20240228.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrsn-20240228_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrsn-20240228_pre.xml EX-101.PRE 22357
20 EXTRACTED XBRL INSTANCE DOCUMENT tm247340d5_8k_htm.xml XML 3491
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 24695343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)